Biweekly schedule of pegylated liposomal doxorubicin (PLD) induces low rates of skin toxicities: Results of a phase-II trial in heavily preteated patients with relapsed ovarian cancer
Year: 2004
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Charité – Universitätsmedizin Berlin
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2300957697
